Europe Particle Therapy Market – Industry Trends and Forecast to 2031

Europe Particle Therapy Market Analysis and Size

The rise of particle therapy market can be seen due to the following drivers -particle therapy can reduce the risk of long-term side effects. The ability to spare healthy tissues from unnecessary radiation exposure is especially important for improving the quality of life for cancer survivors; Technological advancements have made particle therapy more accessible and cost-effective. The development of compact and less expensive proton therapy systems has contributed to the expansion of particle therapy facilities, and increased availability of treatment centers among others.                                

Data Bridge Market Research analyses that the Europe particle therapy market, which was USD 264.10 million in 2023, is expected to reach to USD 474.53 million by 2031, and is expected to undergo a CAGR of 7.60% during the forecast period of 2024-2031. This indicates that the market value. “Proton therapy” dominates the type segment of the particle therapy market since particle therapy is one of the most popular alternative treatment procedures for radiation therapy. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Particle therapy is one of the most advanced types of external beam radiation therapy for oncology in the world. This method saves more healthy radiation tissue than traditional photon therapy. These particles have better physical intrinsic qualities, lowering the intake dose to about half of what a clinically appropriate target would be.

Particle Therapy Market Dynamics

Drivers

• Increasing Incidence of Cancer

The rising incidence of cancer across Europe is a significant driver for the particle therapy market. Particle therapy offers precise tumor targeting while minimizing damage to surrounding healthy tissues, making it particularly beneficial for treating cancers in sensitive areas or those that have not responded well to conventional treatments. As cancer rates continue to rise, there is a growing demand for advanced and effective treatment options such as particle therapy.

• Technological Advancements in Particle Therapy Technology

Ongoing advancements in particle therapy technology have improved treatment outcomes and expanded the applicability of particle therapy in various cancer types. Innovations such as intensity-modulated proton therapy (IMPT), pencil beam scanning, and image-guided particle therapy have enhanced treatment precision, reduced side effects, and increased treatment efficiency. These technological developments make particle therapy increasingly attractive to healthcare providers and patients such as, thereby driving market growth.

• Rising Patient Preferences for Minimally Invasive Treatments

Patients increasingly prefer treatments that offer fewer side effects and better quality of life during and after therapy. Particle therapy's ability to precisely target tumors while sparing healthy tissues from radiation damage aligns with these preferences. As patient-centered care gains prominence in European healthcare systems, the demand for particle therapy as a minimally invasive treatment option continues to rise.

• Growing Investment for Healthcare Facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

• Expansion of Indications and Treatment Modalities

One significant opportunity lies in expanding the indications and treatment modalities for particle therapy. While particle therapy is already used to treat various cancers, including those of the prostate, brain, and pediatric cancers, there is potential for further diversification. Research and clinical trials exploring the efficacy of particle therapy in treating additional cancer types, such as breast cancer, head and neck cancers, and recurrent tumors, present opportunities to broaden the market and increase patient access to this advanced treatment modality.

• Development of Compact and Affordable Treatment Solutions

There is an opportunity for the development of more compact and cost-effective particle therapy solutions tailored to the needs of smaller healthcare facilities and regions with limited resources. Miniaturization of particle therapy equipment, advancements in proton therapy technology, and modular treatment facility designs can help reduce the upfront investment and operating costs associated with establishing particle therapy centers. Offering more affordable and accessible particle therapy solutions can democratize access to advanced cancer care across Europe, particularly in underserved areas.

Restraints/Challenges

• Limited Reimbursement and Insurance Coverage

Reimbursement policies and insurance coverage for particle therapy treatments vary across European countries and healthcare systems. In some cases, reimbursement rates may not adequately cover the costs associated with providing particle therapy, leading to financial challenges for healthcare providers and patients. Additionally, the lack of consistent reimbursement policies and uncertainty regarding insurance coverage can deter investment in particle therapy facilities and impede patient access to these advanced treatments, particularly for underserved populations.

• Competition from Conventional Radiation Therapy

One of the significant challenges facing the particle therapy market in Europe is competition from conventional radiation therapy modalities, such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT). While particle therapy offers advantages in terms of precision and reduced toxicity, conventional radiation therapy remains widely available and less costly to implement. Healthcare providers may be hesitant to invest in particle therapy infrastructure or refer patients to particle therapy centers due to the perceived adequacy of conventional treatments, posing a challenge to market penetration and growth.

• Regulatory and Certification Requirements

Particle therapy facilities in Europe must adhere to stringent regulatory and certification requirements to ensure patient safety and treatment quality. Obtaining regulatory approvals, complying with radiation safety standards, and maintaining accreditation from relevant authorities can be complex and time-consuming processes. The evolving regulatory landscape, including changes in radiation protection regulations and licensing requirements, may pose challenges for particle therapy providers, particularly smaller or newly established facilities, in navigating compliance obligations and ensuring continuous regulatory compliance.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2022, Mevion Medical Systems has been selected to install a MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) in a comprehensive hospital in Southern China
• In April 2022, The Connecticut Office of Health Strategy (OHS) approved with conditions, the certificate of need application to allow Harford HealthCare Corporation and Yale New Haven Health Services Corporation to establish proton therapy services through a newly established joint venture, Connecticut Proton Therapy Center, LLC

Particle Therapy Market Scope

The market is segmented on the basis of type, product & services, system, application and cancer-type. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Proton therapy
• Heavy-Ion therapy

Product and Services

• Products
• Services

 System

• Multi-room systems
• Single-room systems

Application

• Treatment application
• Research application

Cancer-Type

• Paediatric Cancer
• Lung Cancer
• Breast cancer
• Head and
• Other cancers

Europe Particle Therapy Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, type, product and services, system, application and cancer-type as referenced above.

The countries covered in the market report are U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe.

Germany is projected to observe significant amount of growth in the particle therapy market due to the rapid necessity for telemedicine and healthcare support. Moreover, the modernization and development in telecommunication is further anticipated to propel the growth of the particle therapy market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Particle Therapy Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• Advanced Oncotherapy PLC. (U.K.)
• Danfysik A/S (Denmark)
• Hitachi, Ltd. (Japan)
• Ion Beam Applications Sa (IBA) (Belgium)
• Mevion Medical Systems, Inc. (U.S.)
• Optivus Proton Therapy, Inc. (U.S.)
• Protom International, Inc. (U.S.)
• Provision Healthcare, LLC (U.S.)
• Sumitomo Heavy Industries, Ltd. (Japan)
• Varian Medical Systems, Inc. (U.S.)

SKU-70734